Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cell division cycle 7 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | poly(ADP-ribose) polymerase catalytic domain-containing protein | 0.0011 | 0 | 0.5 |
Plasmodium falciparum | replication factor C subunit 1, putative | 0.0011 | 0 | 0.5 |
Echinococcus multilocularis | CDC7 cell division cycle 7 | 0.0069 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0011 | 0 | 0.5 |
Toxoplasma gondii | ATPase, AAA family protein | 0.0011 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0041 | 0.5211 | 0.5211 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0041 | 0.5211 | 0.5211 |
Mycobacterium leprae | PROBABLE DNA LIGASE [NAD DEPENDENT] LIGA (POLYDEOXYRIBONUCLEOTIDE SYNTHASE [NAD+]) | 0.0011 | 0 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0052 | 0.7159 | 0.7159 |
Echinococcus granulosus | CDC7 cell division cycle 7 | 0.0069 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0052 | 0.7159 | 0.7159 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0052 | 0.7159 | 0.7159 |
Trypanosoma cruzi | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0011 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0041 | 0.5211 | 0.5211 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.7159 | 0.7159 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.5211 | 1 |
Trypanosoma cruzi | FHA domain containing protein, putative | 0.0011 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.7159 | 0.7159 |
Treponema pallidum | DNA ligase (lig) | 0.0011 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.5211 | 1 |
Onchocerca volvulus | 0.0069 | 1 | 1 | |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.5211 | 0.5211 |
Plasmodium vivax | replication factor C subunit 1, putative | 0.0011 | 0 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0041 | 0.5211 | 0.5211 |
Mycobacterium ulcerans | NAD-dependent DNA ligase LigA | 0.0011 | 0 | 0.5 |
Trypanosoma brucei | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0011 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0069 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.5211 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.7159 | 0.7159 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0052 | 0.7159 | 0.7159 |
Wolbachia endosymbiont of Brugia malayi | NAD-dependent DNA ligase, Lig | 0.0011 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0052 | 0.7159 | 0.7159 |
Onchocerca volvulus | 0.0069 | 1 | 1 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0011 | 0 | 0.5 |
Giardia lamblia | Kinase, CDC7 | 0.0069 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0069 | 1 | 1 |
Chlamydia trachomatis | DNA ligase | 0.0011 | 0 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0052 | 0.7159 | 0.7159 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0069 | 1 | 1 |
Loa Loa (eye worm) | CDC7 protein kinase | 0.0069 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0069 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.5211 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AUC (ADMET) | = 11.2 uM.hr | AUC (infinity) in Harlan nu/nu mouse at 10 mg/kg, po | ChEMBL. | 20873740 |
AUC (ADMET) | = 20.9 uM.hr | AUC (infinity) in Harlan nu/nu mouse at 10 mg/kg, iv | ChEMBL. | 20873740 |
CL (ADMET) | = 27.3 ml/min.kg | Clearance in Harlan nu/nu mouse at 10 mg/kg, iv | ChEMBL. | 20873740 |
Cmax (ADMET) | = 8.9 uM | Cmax in Harlan nu/nu mouse at 10 mg/kg, po | ChEMBL. | 20873740 |
Cmax (ADMET) | = 58.4 uM | Cmax in Harlan nu/nu mouse at 10 mg/kg, iv | ChEMBL. | 20873740 |
F (ADMET) | = 51 % | Bioavailability in Harlan nu/nu mouse at 10 mg/kg, po | ChEMBL. | 20873740 |
IC50 (binding) | = 0.022 uM | Inhibition of Cdc7 | ChEMBL. | 20873740 |
IC50 (functional) | = 0.26 uM | Antiproliferative activity against human A2780 cells expressing p53 after 72 hrs by celltiter-glo assay | ChEMBL. | 20873740 |
PPB (ADMET) | = 68 % | Plasma protein binding in human serum albumin | ChEMBL. | 20873740 |
T1/2 (ADMET) | = 0.15 hr | Half life in Harlan nu/nu mouse at 10 mg/kg, iv | ChEMBL. | 20873740 |
T1/2 (ADMET) | = 0.7 hr | Half life in Harlan nu/nu mouse at 10 mg/kg, po | ChEMBL. | 20873740 |
Tmax (ADMET) | = 0.25 hr | Tmax in Harlan nu/nu mouse at 10 mg/kg, po | ChEMBL. | 20873740 |
Vdss (ADMET) | = 264 ml/kg | Volume of distribution at steady state in Harlan nu/nu mouse at 10 mg/kg, iv | ChEMBL. | 20873740 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 20873740 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.